Yahoo Web Search

Search results

1. • 

     OSF Healthcare collaboration hopes to improve lung cancer screening rates

     WMBD - FOX 43 Peoria· 3 days ago

     PEORIA, Ill. (WMBD) — OSF Healthcare announced, on Monday, a new partnership that they say will...

2. • 

     What’s behind the fight over high cancer drug dosages

     OregonLive.com· 4 days ago

     When doctors began using the drug sotorasib in 2021 with high expectations for its innovative...

3. • Delfi Diagnostics, OSF HealthCare Partner to Expand Blood-Based Lung Cancer Screening

     GenomeWeb News· 3 days ago

     OSF will begin offering Delfi's liquid biopsy lung cancer screening test to eligible patients, initially at 18 locations and eventually across its full network.

4. • 

     How diet plays a role in prostate cancer risk

     KOAT Albuquerque· 2 days ago

     Prostate cancer is the second-leading cause of cancer deaths in men. The most fatal cancer for U.S. men is lung cancer, but prostate cancer is still the...

5. • 

     Lab-Testing Startups Brace for FDA Rule Change

     The Wall Street Journal· 2 hours ago

     The Food and Drug Administration ruling will increase development costs for lab tests, yet some entrepreneurs and investors welcome the shift.

6. • 

     Warning signs in blood could be used to predict cancer seven years earlier, scientists find

     The Independent via Yahoo News· 1 day ago

     Scientists have discovered proteins in the blood which are linked to the development of dozens of...

7. • 

     Bristol Myers Squibb reports setback in lung cancer trial By Investing.com

     Investing.com· 6 days ago

     Bristol Myers Squibb (NYSE: NYSE:BMY) disclosed that its Phase 3 CheckMate -73L trial for treating a...

8. • Q1 2024 Panbela Therapeutics Inc Earnings Call

     Thomson Reuters StreetEvents via Yahoo Finance· 2 hours ago

     This patent is for claim for the fixed dose combination of eflornithine and sulindac. In summary, our projected first-half 2024 milestones include enrolling our first patient in the non-small ...

9. • 

     InnoCare Pharma concludes subject enrolment Phase II psoriasis trial

     Clinical Trials Arena via Yahoo Finance· 5 hours ago

     In March this year, the company dosed the first patient in a Phase Ib trial to investigate the...

10. • Self-assembled Na-doped zinc oxide for the detection of lung cancer biomarker VOCs at low...

      Phys.org· 3 days ago

      Most metal oxides struggle to respond at such low concentrations, which can impact the early diagnosis of lung cancer. Gas sensors based on metal oxide ...